Avid Bioservices Inc (CDMO)

[stoneroad]

I'm shocked there is not more excitement around the possibilities at Kyoto. Look at the puzzle pieces that have been outlined by CP and EBS.

1. Promising preclinical with Sorafenib.

2. Yopp states in March he is excited about early results of phase 1/2.

3. Yopp looking forward to releasing additional data this year.

4. Yopp becomes a paid consultant for Bayer.

5. Bayer is Diamond (lead) sponsor for Kyoto liver conference.

6. Yopp is attending Kyoto conference.

Perhaps nothing comes of this. However, IMO puzzle pieces indicate a bombshell will be dropped in Kyoto. We'll know in less than 2 weeks. Saying my prayers and crossing my fingers.